QCRH QCR Holdings reports Q1 2026 EPS 85 percent above estimates slips 019 percent in todays trading Public Service Enterprise Group PEG Governance Overhaul and Bullish Fundamental Outlook What Investors Need to Know Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval